Efficacy of Fish Oil or Olive Oil Supplementation on the Health Effects of Ozone Exposure in Healthy Young Subjects
NCT03395119 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 44
Last updated 2021-01-15
Summary
Purpose: A growing body of epidemiological data suggests an increased risk of cardiovascular events associated with air pollution. One of the common air pollutants, ozone, has been shown to induce oxidative stress and inflammation in the cardiovascular and respiratory systems. This proposed study is to examine the efficacy of fish oil and olive oil in modulating cardiovascular and pulmonary functions after ozone exposure. The objective is to understand the mechanistic basis for the health effects of ozone relative to those air pollutants. Treatment groups will include forty healthy young adults who will be given dietary supplementation of fish oil or olive oil. A control group will consist of 20 healthy volunteers who will receive no supplements. After 4 weeks, subjects will be exposed to clean air for 2 hours on the first day, then ozone for 2 hours on the second day. Cardiac rhythm, pulmonary function, vascular responses, endothelial function, and markers of coagulation and airway inflammation pre- and post- ozone exposure will be measured. This study is designed to build on the previous nutritional supplement interventional studies (UNC IRB # 07-0190 and UNC IRB # 11-1807), in order to understand the mechanism of action of particulate pollutants in comparison to that of ozone, a known oxidant air contaminant.
Participants: A total of sixty healthy 18-35 year-old male and female subjects will be involved in the study.
Procedures (methods): Forty healthy young adults will receive dietary supplementation consisting of fish oil or olive oil for 4 weeks. The control group includes 20 healthy volunteers who will receive no supplements in the study. After 4 weeks of supplementation or control regiment, each subject will be exposed to clean air for 2 hours on the first day, then ozone for 2 hours on the second day.
Conditions
- Healthy
- Dietary Supplement
Interventions
- DRUG
-
Ozone
After the four-week supplementation period, each subject will be blindly exposed on consecutive days to filtered air for 2 hours and to 0.3 ppm ozone for 2 hours, while undergoing intermittent moderate exercise (minute ventilation of 20 L/min/m²).
- DIETARY_SUPPLEMENT
-
Fish Oil
3 (1-gram) soft-gels daily Commercially available, enteric-coated, soft-gels formulated to deliver \>60% eicosapentaenoic/docosahexaenoic acids (EPA/DHA)
- DIETARY_SUPPLEMENT
-
Olive Oil
3 soft-gels daily Commercially available soft-gels containing 1 gram of USDA organic certified, cold pressed, extra virgin, olive oil
Sponsors & Collaborators
-
Environmental Protection Agency (EPA)
collaborator FED -
University of North Carolina, Chapel Hill
lead OTHER
Principal Investigators
-
James Samet, PhD · Environmental Protection Agency, University of North Carolina at Chapel Hil
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-12-18
- Primary Completion
- 2020-12-18
- Completion
- 2020-12-18
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Safety & Efficacy of Omega-3 Fish Oil in Overweight Children & Adolescents
NCT00447291 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
NCT03255187 ·Status: COMPLETED ·Phase: NA
-
The Impact of Fish-oil Fatty Acids on Postprandial Vascular Reactivity
NCT01692431 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Fatty Acids on Markers of Inflammation
NCT01129050 ·Status: COMPLETED ·Phase: NA
-
Fish Oil and Asthma in House Dust Mite Allergy
NCT00380926 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Omega 3 Fatty Acid Supplements on Heavy Smokers
NCT03936621 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease
NCT04088240 ·Status: TERMINATED ·Phase: NA
-
Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure
NCT05822141 ·Status: RECRUITING ·Phase: NA
-
Effect of a Mediterranean Diet and Omega-3 Fatty Acids on Oxidative Stress and Endothelial Progenitor Cells (EPC's)
NCT00166088 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation
NCT01078909 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Omega 3 Fatty Acids on Vascular Function
NCT01888211 ·Status: COMPLETED ·Phase: NA
-
The Effects of Omega-3 Fatty Acids on Metabolic Syndrome
NCT00350194 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effects of Omega-3 Fatty Acids on Risk Factors for Breast Cancer in Pre-menopausal Women
NCT02816125 ·Status: COMPLETED ·Phase: PHASE3
-
Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer
NCT00114296 ·Status: UNKNOWN ·Phase: NA
-
Marine n-3 Polyunsaturated Fatty Acids in Pre- and Postmenopausal Women
NCT00901589 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study on the Lipid-lowering Effect of Plant Sterols and Fish Oil
NCT01313988 ·Status: COMPLETED ·Phase: NA
-
Fish Oil and Cardiovascular Suboptimal Health
NCT02103517 ·Status: COMPLETED ·Phase: PHASE3
-
Fish Oil-derived N-3 Polyunsaturated Fatty Acids and Extracellular Vesicles
NCT03203512 ·Status: COMPLETED ·Phase: NA
-
Fish Oil and Inflammation in Overweight Subjects
NCT00885053 ·Status: COMPLETED ·Phase: NA
-
Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer
NCT00253643 ·Status: COMPLETED ·Phase: NA
-
To Evaluate the Effects of Omega 3 Fatty Acids in the Context of Cancer Prevention
NCT05427604 ·Status: COMPLETED ·Phase: NA
-
Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
NCT03372733 ·Status: RECRUITING ·Phase: PHASE2
-
Fish Oil to Prevent Asthma Exacerbations in Patients With ALOX5 Polymorphisms
NCT00621829 ·Status: COMPLETED ·Phase: NA
-
Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers
NCT05121766 ·Status: TERMINATED ·Phase: PHASE1
-
Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia
NCT00627276 ·Status: COMPLETED ·Phase: NA